Acyclovir: Clinical Trials

94 trials of Acyclovir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

68 completed, 15 unknown, 4 recruiting, 3 not yet recruiting. 30 Phase 3, 19 Not applicable, 18 Phase 2, 15 Phase 4, 13 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 330Completed 23, Unknown 4, Recruiting 1, Terminated 1, Withdrawn 1
Not applicable19Completed 13, Unknown 4, Not yet recruiting 2
Phase 218Completed 16, Unknown 1, Withdrawn 1
Phase 415Completed 10, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 113Completed 10, Recruiting 2, Unknown 1

Follow this drug Literature Review of Acyclovir trials Research Report on Acyclovir

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Oral Antiviral Therapy for Idiopathic Trigeminal Neuralgia
Intervention:Drug: Carbamazepine, Intervention:Drug: Carbamazepine + Acyclovir, Intervention:Drug: Carbamazepine + Celecoxib - Idiopathic Trigeminal Neuralgia
Not applicableNot yet recruitingBeijing Tiantan Hospital1652026-08-312026-06-29
Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases
Acyclovir (ACV), Placebo - Autoimmune Rheumatic Diseases, Recurrent Herpes Simplex
Phase 4RecruitingUniversity of Sao Paulo General Hospital622026-06-252026-08-05
Aciclovir Versus Placebo for HSV-2 Meningitis
Acyclovir 50 MG/ML, Placebo - Herpes Simplex 2, Meningitis, Viral
Phase 4Not yet recruitingJacob Bodilsen1502026-06-012025-10-01
Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis
Acyclovir 400 MG, Ganciclovir (GCV) - Herpetic Keratitis
Not applicableCompletedAl-Azhar University202024-10-012025-01-03
Individualization of Dosage Regimens in Obese Patients: Application to Acyclovir
Acyclovir - Obesity
Phase 1RecruitingUniversity Hospital, Toulouse202024-04-092025-12-31
Preemptive Treatment With Acyclovir in Intubated and Mechanically Ventilated Patients With Herpes (PTH2)
Intravenous acyclovir (ACYCLOVIR ), Saline bags - Invasive Mechanical Ventilation, HSV Throat Reactivation
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris2462024-03-012024-01-22
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Acyclovir - Pneumonia, Viral, Ventilator Associated Pneumonia
Phase 3RecruitingJena University Hospital6162024-02-202026-07-23
The Bioequivalence Study of Acyclovir 800 mg Tablet in Healthy Thai Volunteers Under Fasting Conditions
Acyclovir 800 mg Tablet, Zovirax™ 800 mg Tablet - Healthy Volunteer
Phase 1UnknownInternational Bio service402024-02-122024-01-29
Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts
Vitamin D, acyclovir - Plantar Wart
Not applicableUnknownAssiut University442022-10-012022-04-13
Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts
Acyclovir 250mg Powder for Solution for Infusion, each vial contains 250mg of acyclovir as the sodium salt, Chandra Bhagat Pharma Pvt. Ltd andcandida antigen - Acyclovir and Candida Antigen in Treatment of Plantar Wart
Phase 4UnknownSohag University402022-06-132022-06-23
Effect of Various Treatment Modalities on Dendritic Vial Ulcer
Acyclovir, Tobramycin, Fluorometholone - Corneal Ulcer
UnknownSohag University402022-03-182022-04-06
A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally
Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773, Placebo - Recurrent Herpes Labialis
Phase 3CompletedBayer20202021-11-232025-09-02
The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children
Acyclovir, KOH 10 % - Molluscum Contagiosum
Not applicableUnknownDalia Mahran352020-06-152020-07-20
Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject
Acyclovir 200 MG, Acyclovir 400 MG, Zovirax 200 MG Tablet - Drug Use
Not applicableCompletedPT. Kimia Farma (Persero) Tbk562020-02-212023-02-09
Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis
oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily, oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops - Herpes Simplex Virus Keratitis
Phase 4WithdrawnNYU Langone Health2019-12-102022-01-14
Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)
Piperacillin/tazobactam, Meropenem, Daptomycin - Therapeutic Drug Monitoring, Subarachnoid Hemorrhage
UnknownAzienda Sanitaria-Universitaria Integrata di Udine1042019-10-012021-07-21
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
ASP7317, tacrolimus, trimethoprim-sulfamethoxazole - Age-Related Macular Degeneration
Phase 1RecruitingAstellas Institute for Regenerative Medicine422018-07-132026-09-03
Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)
Letermovir, Valganciclovir, Acyclovir (ACV) - CMV Disease
Phase 3CompletedMerck Sharp & Dohme LLC6012018-05-032023-07-28
EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug
Acyclovir 800 MG, Radiotherapy and chemotherapy - Drug Use for Unapproved Schedule
Phase 3UnknownKuwait Cancer Control Center502018-05-012018-09-04
Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)
Microdebrider, Cold-steel surgery (forceps), Carbon dioxide laser - Recurrent Respiratory Papillomatosis, Human Papilloma Virus
UnknownNewcastle-upon-Tyne Hospitals NHS Trust4002018-04-012022-01-11

Showing 20 of 94. Sign in to see all of them.

Conditions studied

Herpes Simplex (25)  ·  HIV Infections (20)  ·  Herpes Genitalis (13)  ·  Acquired Immunodeficiency Syndrome (12)  ·  AIDS-Related Complex (7)  ·  Herpes Labialis (6)  ·  Herpesviridae Infections (5)  ·  AIDS-Related Opportunistic Infections (4)  ·  Communicable Diseases (4)  ·  Herpes Zoster (4)  ·  Immune System Diseases (4)  ·  Infections (4)  ·  Rare Diseases (4)  ·  Virus Diseases (4)  ·  Cytomegalovirus Infections (3)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (12)  ·  University of Washington (7)  ·  Glaxo Wellcome (5)  ·  Genzyme, a Sanofi Company (4)  ·  National Center for Research Resources (NCRR) (4)  ·  EMS (3)  ·  Fred Hutchinson Cancer Center (3)  ·  Assiut University (2)  ·  Centers for Disease Control and Prevention (2)  ·  Medivir (2)  ·  National Eye Institute (NEI) (2)  ·  Sohag University (2)  ·  University of Sao Paulo General Hospital (2)  ·  Al-Azhar University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (42)  ·  Canada (6)  ·  France (6)  ·  United Kingdom (6)  ·  Brazil (5)  ·  Egypt (5)  ·  Germany (5)  ·  Italy (5)  ·  China (3)  ·  Spain (3)  ·  Australia (2)  ·  Austria (2)  ·  Belgium (2)  ·  Israel (2)  ·  Poland (2)

Top investigators

Anna Wald, MD, MPH (5)  ·  Connie Celum, MD, MPH (4)  ·  Corey L (2)  ·  David W. Kimberlin (2)  ·  Richard J. Whitley (2)  ·  A-Dong Shen, Master (1)  ·  A. D'jamali, MD, MS (1)  ·  Adam Donne (1)  ·  Aldo Lucchetti, MD (1)  ·  Asode A Shetty, MD, PhD, MCh, FRCS (1)  ·  Brian Hill, MD, PhD (1)  ·  CA Benson (1)

Results publications

PMID 21991950, PMID 22225814, PMID 39251561, PMID 16282339, PMID 1646585, PMID 18081360, PMID 18572080, PMID 18667923, PMID 18846389, PMID 19050195, PMID 19530940, PMID 19715417, PMID 19838129, PMID 20214474, PMID 20443734, PMID 20702659, PMID 20851499, PMID 21099672, PMID 21104007, PMID 21150554, PMID 21320979, PMID 21998479, PMID 22183840, PMID 22433279, PMID 23254142, PMID 24569417, PMID 25155587, PMID 25473327, PMID 25628457, PMID 25749169, PMID 25904747, PMID 26289222, PMID 26375604, PMID 2653790, PMID 26755499, PMID 27689547, PMID 28437539, PMID 29146146, PMID 29507070, PMID 29746903, PMID 29747074, PMID 2992899, PMID 30921087, PMID 30962334, PMID 31841577, PMID 32129861, PMID 33020163, PMID 37279999, PMID 38670599, PMID 38700045

NIH funding

2014 (2), 2016 (2), N01AI30025 (2), 2015 (1), 2017 (1), 2023 (1), K23AI071257 (1), P01AI030731 (1), P30CA012197 (1), R01AI050132 (1), R01AI052054 (1), U01AI047981 (1), U01AI052054 (1), U10CA031946 (1), U19AI031448 (1)